British Committee for Standards in Haematology Guidelines

Guideline for the treatment of chronic lymphocytic leukaemia
Renata Walewska,Nilima Parry-Jones,Toby A. Eyre,George Follows,Nicolas Martinez-Calle,Helen McCarthy,Helen Parry,Piers E. M. Patten,John C. Riches,Peter Hillmen,Anna H. Schuh
First published: 21 March 2022

GPP Management of cardiovascular complications of bruton tyrosine kinase inhibitors

Guideline for the treatment of chronic lymphocytic leukaemia

Schuh et al. Guideline for the treatment of chronic lymphocytic leukaemia. Br J Haematol. 2018 Aug;182(3):344-359

Eyre et al. Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper. Br J Haematol 2022 Feb;196(4):864-870.

International Workshop on CLL Guidelines

Hallek et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018 Jun 21;131(25):2745-2760

How I treat/manage articles

Wierda W.G., Tambaro F.P. How I Manage CLL with Venetoclax-Based Treatments Blood 2020

Gribben J.G. How and when I do allogeneic transplant in CLL. Blood. 2018 Jul 5;132(1):31-39

Stephens D.M., Byrd J.C. How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia. Blood. 2019 Mar 21;133(12):1298-1307.

Rossi et al. Biology and treatment of Richter syndrome. Blood. 2018 Jun 21;131(25):2761-2772.

Brown J.R. How I treat CLL patients with ibrutinib. Blood. 2018 Jan 25;131(4):379-386.